본문 바로가기
KERD
논문KCI 등재

손발톱진균증의 치료효과 증가

Increasing Therapeutic Efficacy for Onychomycosis

김우일|고현창
대한의진균학회 (The Korean Society for Medical Mycology)|2016.09|대한의진균학회지 (Journal of Mycology and Infection)|제21권 제3호|pp. 59-64|DOI 10.17966/kjmm.2016.21.3.59

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

Treatment outcomeOnychomycosisAntifungal agents
주제분류미생물학

초록

Onychomycosis is a chronic fungal nail infection which is notoriously difficult to eradicate. In spite of the selection of appropriate oral or topical antifungal medications, treatment failure or recurrences are frequent. Different therapeutic strategies must have been considered to improve the short- and long-term efficacy outcomes. These strategies are followed as: (1) correct diagnosis and classification of onychomycosis, (2) individually tailored treatment regimen, (3) maximizing method of antifungal efficacy, (4) reducing relapse and reinfection.

Abstract

Onychomycosis is a chronic fungal nail infection which is notoriously difficult to eradicate. In spite of the selection of appropriate oral or topical antifungal medications, treatment failure or recurrences are frequent. Different therapeutic strategies must have been considered to improve the short- and long-term efficacy outcomes. These strategies are followed as: (1) correct diagnosis and classification of onychomycosis, (2) individually tailored treatment regimen, (3) maximizing method of antifungal efficacy, (4) reducing relapse and reinfection.

참고문헌 (31)

  1. Scher RK, "Advances in the diagnosis and treatment of onychomycosis", Hosp Med, 34, pp.11~20 (1998)
  2. Elkeeb R, "Emerging topical onychomycosis therapies - quo vadis?", Expert Opin Emerg Drugs, 19, pp.489~495 (2014)
  3. Gupta A, "How effective is efinaconazole in the management of onychomycosis?", Expert Opin Pharmacother, 17, pp.611~618 (2016)
  4. Gupta AK, "Therapies for the treatment of onychomycosis", Clin Dermatol, 31, pp.544~554 (2013)
  5. Drake LA, "Oral terbinafine in the treatment of toenail onychomycosis : North American multicenter trial", J Am Acad Dermatol, 37, pp.740~745 (1997)
  6. Piraccini BM, "Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents", J Am Acad Dermatol, 62, pp.411~414 (2010)
  7. 김원정, "손발톱진균증으로 오진 후 항진균제가 투여된 손발톱질환에 대한 임상적 연구", 대한피부과학회지, 49(05), pp.408~414 (2011), 대한피부과학회
  8. Gupta AK, "Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature", J Cutan Med Surg, 5, pp.206~210 (2001)
  9. Bueno JG, "In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis", Clin Exp Dermatol, 35, pp.658~663 (2010)
  10. Arrese JE, "A plea to bridge the gap between antifungals and the management of onychomycosis", Am J Clin Dermatol, 2, pp.281~284 (2001)
  11. Flagothier C, "New insights into the effect of amorolfine nail lacquer", Mycoses, 48, pp.91~94 (2005)
  12. Piérard GE, "The boosted antifungal topical treatment(BATT)for onychomycosis", Med Mycol, 38, pp.391~392 (2000)
  13. Piérard GE, "The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen", Dermatology, 200, pp.185~187 (2000)
  14. Fanning S, "Fungal biofilms", PLoS Pathog, 8, pp.e1002585~ (2012)
  15. Gupta A, "The role of biofilms in onychomycosis", J Am Acad Dermatol, 74, pp.1241~1246 (2016)
  16. Rajendran R, "Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms", Eukaryot Cell, 12, pp.420~429 (2013)
  17. Ramage G, "Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule", Appl Environ Microbiol, 68, pp.5459~5463 (2002)
  18. Carlson RP, "Anti-biofilm properties of chitosan-coated surfaces", J Biomater Sci Polym Ed, 19, pp.1035~1046 (2008)
  19. Busscher HJ, "Streptococcus thermophilus and its biosurfactants inhibit adhesion by Candida spp. on silicone rubber", Appl Environ Microbiol, 63, pp.3810~3817 (1997)
  20. Murzyn A, "Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation", PLoS One, 5, pp.e12050~ (2010)
  21. Westerberg DP, "Onychomycosis : Current trends in diagnosis and treatment", Am Fam Physician, 88, pp.762~770 (2013)
  22. Gupta AK, "Drug interactions with itraconazole, fluconazole, and terbinafine and their management", J Am Acad Dermatol, 41, pp.237~249 (1999)
  23. Willems L, "Itraconazole oral solution and intravenous formulations : a review of pharmacokinetics and pharmacodynamics", J Clin Pharm Ther, 26, pp.159~169 (2001)
  24. Quintanar-Guerrero D, "The effect of keratolytic agents on the permeability of three imidazole antimycotic drugs through the human nail", Drug Dev Ind Pharm, 24, pp.685~690 (1998)
  25. Bassiri-Jahromi S, "A comparative evaluation of combination therapy of fluconazole 1% and urea 40%compared with fluconazole 1% alone in a nail lacquer for treatment of onychomycosis : therapeutic trial", J Dermatol Treat, 23, pp.453~456 (2012)
  26. Grover C, "An update on treatment of onychomycosis", Mycoses, 55, pp.541~551 (2012)
  27. Gupta AK, "How to improve cure rates for the management of onychomycosis", Dermatol Clin, 21, pp.499~505 (2003)
  28. Gupta AK, "Evidencebased optimal fluconazole dosing regimen for onychomycosis treatment", J Dermatolog Treat, 24, pp.75~80 (2013)
  29. Sigurgeirsson B, "Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis : a 5-year blinded prospective follow-up study", Arch Dermatol, 138, pp.353~357 (2002)
  30. Yin Z, "A meta-analysis comparing longterm recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole", J Dermatol Treat, 23, pp.449~452 (2012)
  31. Gudnadóttir G, "Onychomycosis in Icelandic swimmers", Acta Derm Venereol, 79, pp.376~377 (1999)

관련 논문AI추천

손발톱진균증의 국소치료이양원, 이지현대한의진균학회 · 대한의진균학회지2016 · 제21권 제2호손발톱진균증의 전신 항진균제김기홍, 김효진, 박소희대한의진균학회 · 대한의진균학회지2016 · 제21권 제4호Korean Guideline for the Diagnosis and Treatment of Onychomycosis: Purpose and Process of Algorithm Guideline Development박진, 고현창, 김광호, 김효진, 남재희, 문제호, 박준수, 서무규, 이양원, 이원주, 이지범, 이지현, 최종수대한의진균학회 · 대한의진균학회지2018 · 제23권 제2호발톱진균증의 침범 정도에 따른 완치율과 정상화까지의 기간 및 재발률강명승, 김정수, 유희준대한의진균학회 · 대한의진균학회지2008 · 제13권 제2호발톱진균증 환자에서 환자의 임상적 특성 및 치료방법에 따른 KOH 검사 음성전환기간의 비교강명승, 김정수, 백준오, 유희준대한의진균학회 · 대한의진균학회지2013 · 제18권 제1호경구항진균제, Nail Lacquer 국소도포와 함께 손발톱 밑으로 항진균제를 직접 주입하여 완치를 보인 피부사상균종 (Dermatophytoma)를 동반한 손발톱진균증김기홍, 김미혜, 김영식, 신동훈, 최종수대한의진균학회 · 대한의진균학회지2010 · 제15권 제3호

이 간행물의 다른 논문 (7건)

에머리보드와 수술용 블레이드를 이용한 손발톱진균증의 진균 배양 검사 양성율에 대한 비교 연구박은주, 김민석, 조은별, 김광호, 권원주, 김광중pp. 65-72파열된 표피낭종으로 오인된 두부 독창이준범, 조현재, 오병호pp. 73-77기관지폐암으로 오인된 면역 정상 환자의폐 효모균증 1예이진영, 장태원, 옥철호, 정만홍, 김제훈pp. 78-83Purpureocillium lilacinum 에 의한 진균 각막염 1예: 국내 증례의 미생물학적 고찰김재력, 성홍섭, 장정현, 김덕희, 김미나pp. 84-91노인에서 발생한 Trichophyton rubrum 에 의한 백선종창윤상열, 서무규, 이종임, 박민우, 최종수, 하경임pp. 92-97
원문 보기